Main > NEUROLOGY. > USA. A. hATTR>Treat.>Patisiran

---

USA. A. hATTR>Treat.>Patisiran's subsections
(*) BR Approval Date: 2020. 02.26.
(*) DE Launch Date: 2018. 10.02.
(*) EU Approval Date: 2018. 08.30.
(*) JP Approval Date: 2019. 06.18.
(*) USA Approval Date: 2018. 08.10.
Company
hATTR: hereditary TransThyretin-med
IV Infusion Once Every 3 Weeks
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2018. 08.07.
RNA Interference
RTM
RTM Web-Site

USA. A. hATTR>Treat.>Patisiran's products
This section has no products